Evidence map›Paper›PMID 32147764›Full record

ArticleBulletin of experimental biology and medicine2020

Study of Antiviral Activity of Metabolites of a New Serratia species K-57 Strain.

L I Puchkova, I S Andreeva, N A Mazurkova, E I Filippova, A S Safatov

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bulletin of experimental biology and medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

L I PuchkovaVector State Research Center of Virology and Biotechnology, Koltsovo, Novosibirsk region, Russia. puchkova@vector.nsc.ru.
I S AndreevaVector State Research Center of Virology and Biotechnology, Koltsovo, Novosibirsk region, Russia.
N A MazurkovaVector State Research Center of Virology and Biotechnology, Koltsovo, Novosibirsk region, Russia.
E I FilippovaVector State Research Center of Virology and Biotechnology, Koltsovo, Novosibirsk region, Russia.
A S SafatovVector State Research Center of Virology and Biotechnology, Koltsovo, Novosibirsk region, Russia.
State Research Center of Virology and Biotechnology VECTOR · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The results of studies of a newly isolated Serratia species K-57 strain are presented. The strain is characterized by antiviral activity towards human influenza A/Aichi/2/68/H3N2, vaccinia, mouse smallpox, and herpes simplex-2 viruses. The detected characteristics of the strain, including the data on activities on nucleolytic enzymes, recommend it for the development of therapeutic and preventive antiviral drugs.

Indexed as

AnimalsAntiviral AgentsBacterial ProteinsChlorocebus aethiopsDeoxyribonucleasesDogsHerpesvirus 2, HumanHumansInfluenza A Virus, H3N2 SubtypeMadin Darby Canine Kidney CellsMiceMicrobial Sensitivity TestsRibonucleasesSerratiaVaccinia virusVariola virusAntiviral AgentsBacterial ProteinsDeoxyribonucleasesRibonucleaseshuman influenza A/H3N2 virusmouse smallpoxSerratia genus nucleasesvaccinia; herpes simplex-2 viruses

Identifiers

PMID32147764
PMCPMC7223097
OpenAlexW3009268520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.